0
0

Cure the Coronavirus Act

2/8/2022, 11:17 PM

Congressional Summary of HR 6019

Cure the Coronavirus Act

This bill expands the tropical disease priority review voucher program to include COVID-19 (a respiratory disease caused by a novel coronavirus), thereby providing manufacturers with incentives for development of a vaccine.

Current Status of Bill HR 6019

Bill HR 6019 is currently in the status of Bill Introduced since February 28, 2020. Bill HR 6019 was introduced during Congress 116 and was introduced to the House on February 28, 2020.  Bill HR 6019's most recent activity was Referred to the House Committee on Energy and Commerce. as of February 28, 2020

Bipartisan Support of Bill HR 6019

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
8
Democrat Cosponsors
6
Republican Cosponsors
2
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 6019

Primary Policy Focus

Health

Potential Impact Areas

- Cardiovascular and respiratory health
- Drug safety, medical device, and laboratory regulation
- Emergency medical services and trauma care
- Infectious and parasitic diseases

Alternate Title(s) of Bill HR 6019

Cure the Coronavirus Act
To expand the tropical disease product priority review voucher program to encourage treatments for coronavirus.
Cure the Coronavirus Act

Comments